Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00645905 · COMPLETED
Trial details
- NCT number
- NCT00645905
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2005-03-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.